HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroblastoma cells for testing neuroprotective drug effects.

Abstract
An attempt was made to use neuroblastoma cells for testing neuroprotective drug effects. To achieve cellular damage, cytotoxic hypoxia was induced in neuroblastoma cells after 10 days in culture by addition of sodium cyanide (1 mmol/L) to the culture medium and was terminated after 6 hr by replacing the cyanide-containing fresh nutrient medium. During this hypoxic period cells were additionally deprived of glucose. They were allowed to recover for another 7 days. Drugs were available to the cells from 30 min prior to hypoxia until 24 hr after hypoxia. Cell concentration of high-energy phosphates and culture protein content were determined as representatives for the posthypoxic development of cell damage, cell activity and viability. While barbiturates and phenytoin revealed neurotoxic effects when applied in doses higher than 300 mumol/L, chlorpromazine, dizocilpine, ketamine, ketazocine, naftidrofuryl, and flunarizine protected neuroblastoma cells against hypoxic damage. These results were comparable to those obtained from primary cultures of neurons under similar experimental conditions. In addition, they were in keeping with neuroprotective drug effects obtained from in vivo experiments. It is suggested that neuroblastoma cells are suitable for testing neuroprotective drug effects.
AuthorsB Peruche, J Krieglstein
JournalJournal of pharmacological methods (J Pharmacol Methods) Vol. 26 Issue 2 Pg. 139-48 (Sep 1991) ISSN: 0160-5402 [Print] United States
PMID1943124 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Central Nervous System Depressants
  • N-Methylaspartate
  • Pentobarbital
Topics
  • Cell Hypoxia
  • Central Nervous System Depressants (pharmacology)
  • N-Methylaspartate (antagonists & inhibitors)
  • Neuroblastoma (pathology)
  • Neurons (drug effects)
  • Pentobarbital (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: